Augmented production of transforming growth factor-β by cultured peripheral blood mononuclear cells from patients with systemic sclerosis

Archives of Dermatological Research

Volumn 296, Issue 2, 2004, Pages 89-93

  Hasegawa, Minoru ^a   Sato, Shinichi ^a   Takehara, Kazuhiko ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Peripheral blood mononuclear cells; Systemic sclerosis; TGF

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE SUBPOPULATION; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SYSTEMIC SCLEROSIS; T LYMPHOCYTE ACTIVATION;

ADULT; CASE-CONTROL STUDIES; CELLS, CULTURED; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; PREDNISOLONE; SCLERODERMA, DIFFUSE; SCLERODERMA, LIMITED; SCLERODERMA, SYSTEMIC; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

EID: 3543094383     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-004-0472-5     Document Type: Article

References (19)

1. Takehara K (2003) Hypothesis: pathogenesis of systemic sclerosis. J Rheumatol 30:755-759
2. Sato S (1999) Abnormalities of adhesion molecules and chemokines in scleroderma. Curr Opin Rheumatol 11:503-507
3. Denton CP, Abraham DJ (2001) Transforming growth factor-β and connective tissue growth factor: key cytokines in scleroderma pathogenesis. Curr Opin Rheumatol 13:505-511
4. LeRoy EC, Smith EA, Kahaleh MB, Trojanowska M, Silver RM (1989) A strategy for determining the pathogenesis of systemic sclerosis: is transforming growth factor β the answer? Arthritis Rheum 32:817-825
5. Spom MB, Roberts AB (1992) Transforming growth factor-β: recent progress and new challenges. J Cell Biol 119:1017-1021
6. Snowden N, Coupes B, Herrick A, Illingworth K, Jayson MI, Brenchley PE (1994) Plasma TGF β in systemic sclerosis: a cross-sectional study. Ann Rheum Dis 53:763-767
7. Higley H, Persichitte K, Chu S, Waegell W, Vancheeswaran R, Black C (1994) Immunocytochemical localization and serologic detection of transforming growth factor β1: association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon. Arthritis Rheum 37:278-288
8. Falanga V, Julien JM (1990) Observations in the potential role of transforming growth factor- β in cutaneous fibrosis. Systemic sclerosis. Ann N Y Acad Sci 593:161-171
9. Giacomelli R, Cipriani P, Danese C, Pizzuto F, Lattanzio R, Parzanese I, et al (1996) Peripheral blood mononuclear cells of patients with systemic sclerosis produce increased amounts of interleukin 6, but not transforming growth factor β1. J Rheumatol 23:291-296
10. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581-590
11. LeRoy EC, Krieg T, Black C, Medsger TAJ, Fleischmajer R, Rowell N, et al (1988) Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis. J Rheumatol 15:202-205
12. Sato S, Ihn H, Kikuchi K, Takehara K (1994) Antihistone antibodies in systemic sclerosis: association with pulmonary fibrosis. Arthritis Rheum 37:391-394
13. Clements PJ, Lachenbruch PA, Seibold JR, Zee B, Steen VD, Brennan P, et al (1993) Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 20:1892-1896
14. Gruschwitz M, Muller PU, Sepp N, Hofer E, Fontana A, Wick G (1990) Transcription and expression of transforming growth factor type β in the skin of progressive systemic sclerosis: a mediator of fibrosis? J Invest Dermatol 94:197-203
15. Kulozik M, Hogg A, Lankat-Buttgereit B, Krieg T (1990) Colocalization of Transforming growth factor β2 with α1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis. J Clin Invest 86:917-922
16. Rossi P, Karsenty G, Roberts AB, Roche NS, Spom MB, de Crombrugghe B (1988) A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor- β. Cell 52:405-414
17. Steen VD (1996) Organ involvement: renal. In: Clements PJ, Furst DE, (eds) Systemic sclerosis. Williams & Wilkins, Baltimore, pp 605-606
18. Ishikawa O, Ishikawa H (1992) Macrophage infiltration in the skin of patients with systemic sclerosis. J Rheumatol 19:1202-1206
19. Kraling BM, Maul GG, Jimenez SA (1995) Mononuclear cellular infiltrates in clinically involved skin from patients with systemic sclerosis of recent onset predominantly consist of monocytes/macrophages. Pathobiology 63:48-56